These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7881646)

  • 1. Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma, Contributions of interleukin-5 and granulocyte/macrophage colony-stimulating factor.
    Adachi T; Motojima S; Hirata A; Fukuda T; Makino S
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):618-23. PubMed ID: 7881646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity.
    Koller DY; Nething I; Otto J; Urbanek R; Eichler I
    Am J Respir Crit Care Med; 1997 Mar; 155(3):1050-4. PubMed ID: 9116985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay.
    Adachi T; Motojima S; Hirata A; Fukuda T; Kihara N; Makino S
    Clin Exp Allergy; 1996 May; 26(5):557-62. PubMed ID: 8735868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction.
    Ohnishi T; Kita H; Weiler D; Sur S; Sedgwick JB; Calhoun WJ; Busse WW; Abrams JS; Gleich GJ
    Am Rev Respir Dis; 1993 Apr; 147(4):901-7. PubMed ID: 8466126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma.
    Woolley KL; Adelroth E; Woolley MJ; Ellis R; Jordana M; O'Byrne PM
    Eur Respir J; 1994 Sep; 7(9):1576-84. PubMed ID: 7995384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum.
    Keatings VM; O'Connor BJ; Wright LG; Huston DP; Corrigan CJ; Barnes PJ
    J Allergy Clin Immunol; 1997 May; 99(5):693-8. PubMed ID: 9155837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eosinophil activation in acute asthma attacks evaluated by electronmicroscopic findings of eosinophils and the concentration of eosinophil cationic protein in sputum].
    Oohashi Y; Motojima S; Kushima A; Tateishi K; Fukuda T; Makino S
    Arerugi; 1991 Oct; 40(10):1265-71. PubMed ID: 1772349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma.
    Woolley KL; Adelroth E; Woolley MJ; Ellis R; Jordana M; O'Byrne PM
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1915-24. PubMed ID: 7767540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum.
    Obase Y; Shimoda T; Mitsuta K; Matsuo N; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):304-10. PubMed ID: 11289329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis.
    Hoshi H; Ohno I; Honma M; Tanno Y; Yamauchi K; Tamura G; Shirato K
    Clin Exp Allergy; 1995 Aug; 25(8):720-8. PubMed ID: 7584683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship of eosinophil viability enhancing activity in sputum and clinical symptoms in asthma].
    Atsuta J; Fujisawa T; Iguchi K
    Arerugi; 1996 Oct; 45(10):1082-8. PubMed ID: 8958654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients.
    Dente FL; Carnevali S; Bartoli ML; Cianchetti S; Bacci E; Di Franco A; Vagaggini B; Paggiaro P
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):312-20. PubMed ID: 17042136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil activation markers in induced sputum in asthmatics.
    Jang AS; Choi IS
    Korean J Intern Med; 2000 Jan; 15(1):1-7. PubMed ID: 10714084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
    Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
    Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma.
    Motojima S; Akutsu I; Fukuda T; Makino S; Takatsu K
    Allergy; 1993; 48(17 Suppl):98-106; discussion 110-1. PubMed ID: 8109721
    [No Abstract]   [Full Text] [Related]  

  • 16. [Creola bodies and the eosinophil cationic protein in sputum in acute asthmatic attacks with respect to their clinical significance].
    Ogata H; Motojima S; Fukuda T; Makino S
    Arerugi; 1990 Dec; 39(12):1567-75. PubMed ID: 2096802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways.
    Park CS; Choi YS; Ki SY; Moon SH; Jeong SW; Uh ST; Kim YH
    Eur Respir J; 1998 Oct; 12(4):872-8. PubMed ID: 9817161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor (MIF) in bronchial asthma.
    Yamaguchi E; Nishihira J; Shimizu T; Takahashi T; Kitashiro N; Hizawa N; Kamishima K; Kawakami Y
    Clin Exp Allergy; 2000 Sep; 30(9):1244-9. PubMed ID: 10971470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma.
    Fujimoto K; Kubo K; Matsuzawa Y; Sekiguchi M
    Chest; 1997 Nov; 112(5):1241-7. PubMed ID: 9367463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro.
    Tai PC; Sun L; Spry CJ
    Clin Exp Immunol; 1991 Aug; 85(2):312-6. PubMed ID: 1864012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.